|
US3923939A
(en)
*
|
1974-06-07 |
1975-12-02 |
Alza Corp |
Process for improving release kinetics of a monolithic drug delivery device
|
|
GB1576376A
(en)
*
|
1977-03-30 |
1980-10-08 |
Benzon As Alfred |
Multiple-unit drug dose
|
|
US4264573A
(en)
*
|
1979-05-21 |
1981-04-28 |
Rowell Laboratories, Inc. |
Pharmaceutical formulation for slow release via controlled surface erosion
|
|
US4226849A
(en)
*
|
1979-06-14 |
1980-10-07 |
Forest Laboratories Inc. |
Sustained release therapeutic compositions
|
|
US4547358A
(en)
*
|
1980-05-06 |
1985-10-15 |
Mead Johnson & Company |
Sustained release tablet containing at least 95 percent theophylline
|
|
US4465660A
(en)
*
|
1981-04-01 |
1984-08-14 |
Mead Johnson & Company |
Sustained release tablet containing at least 95 percent theophylline
|
|
US4985017A
(en)
*
|
1981-07-13 |
1991-01-15 |
Alza Corporation |
Parenteral therapeutical system comprising drug cell
|
|
EP0094116A3
(en)
*
|
1982-05-06 |
1984-08-01 |
The Procter & Gamble Company |
Therapeutic granules
|
|
US4415547A
(en)
*
|
1982-06-14 |
1983-11-15 |
Sterling Drug Inc. |
Sustained-release pharmaceutical tablet and process for preparation thereof
|
|
HU187215B
(en)
*
|
1983-01-26 |
1985-11-28 |
Egyt Gyogyszervegyeszeti Gyar |
Method for producing pharmaceutical product of high actor content and prolonged effect
|
|
DE3435325A1
(de)
*
|
1983-04-09 |
1986-04-17 |
Nikken Chemicals Co., Ltd., Tokio/Tokyo |
Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
|
|
WO1984004674A1
(en)
*
|
1983-05-31 |
1984-12-06 |
Jang Choong Gook |
Dry direct compression compositions for controlled release dosage forms
|
|
US4590062A
(en)
*
|
1984-04-16 |
1986-05-20 |
Tech Trade Corp. |
Dry direct compression compositions for controlled release dosage forms
|
|
US4772475A
(en)
*
|
1985-03-08 |
1988-09-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Controlled-release multiple units pharmaceutical formulation
|
|
GB8521350D0
(en)
*
|
1985-08-28 |
1985-10-02 |
Euro Celtique Sa |
Analgesic composition
|
|
US4810501A
(en)
*
|
1986-06-17 |
1989-03-07 |
Warner-Lambert Company |
Sustained release pharmaceutical preparations
|
|
US4994276A
(en)
*
|
1988-09-19 |
1991-02-19 |
Edward Mendell Co., Inc. |
Directly compressible sustained release excipient
|
|
US4837030A
(en)
*
|
1987-10-06 |
1989-06-06 |
American Cyanamid Company |
Novel controlled release formulations of tetracycline compounds
|
|
US4851226A
(en)
*
|
1987-11-16 |
1989-07-25 |
Mcneil Consumer Products Company |
Chewable medicament tablet containing means for taste masking
|
|
US5135757A
(en)
*
|
1988-09-19 |
1992-08-04 |
Edward Mendell Co., Inc. |
Compressible sustained release solid dosage forms
|
|
US5128143A
(en)
*
|
1988-09-19 |
1992-07-07 |
Edward Mendell Co., Inc. |
Sustained release excipient and tablet formulation
|
|
US5169639A
(en)
*
|
1988-09-19 |
1992-12-08 |
Edward Mendell Co., Inc. |
Controlled release verapamil tablets
|
|
EP0522128B1
(en)
*
|
1991-01-30 |
1996-01-17 |
The Wellcome Foundation Limited |
Water-dispersible tablets
|
|
US5629016A
(en)
*
|
1991-01-30 |
1997-05-13 |
Glaxo Wellcome Inc. |
Water-dispersible tablets
|
|
GB9215908D0
(en)
*
|
1992-07-27 |
1992-09-09 |
Wellcome Found |
Water dispersible tablets
|
|
US5472711A
(en)
*
|
1992-07-30 |
1995-12-05 |
Edward Mendell Co., Inc. |
Agglomerated hydrophilic complexes with multi-phasic release characteristics
|
|
CA2150119C
(en)
*
|
1992-11-30 |
2005-03-15 |
Robert C. Cuca |
Tastemasked pharmaceutical materials
|
|
NZ260408A
(en)
*
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
|
US5698226A
(en)
*
|
1993-07-13 |
1997-12-16 |
Glaxo Wellcome Inc. |
Water-dispersible tablets
|
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
FR2760190B1
(fr)
*
|
1997-02-28 |
1999-04-09 |
Adir |
Composition pharmaceutique pour la liberation programmee de dexfenfluramine
|
|
IN186245B
(US06486227-20021126-C00005.png)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
HU1500214D0
(hu)
|
1997-12-22 |
2002-03-28 |
Euro Celtique Sa |
Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
|
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
|
AUPQ573300A0
(en)
|
2000-02-21 |
2000-03-16 |
Australian Nuclear Science & Technology Organisation |
Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
|
|
ES2361148T3
(es)
|
2001-05-11 |
2011-06-14 |
Endo Pharmaceuticals Inc. |
Forma de dosificación de opioides de liberación controlada resistente al abuso.
|
|
EP2425823A1
(en)
|
2002-04-05 |
2012-03-07 |
Euro-Celtique S.A. |
Pharmaceutical preparation containing oxycodone and naloxone
|
|
MXPA06000702A
(es)
*
|
2003-07-23 |
2006-04-11 |
Perrigo L Co |
Composicion que contiene fibra celulosica.
|
|
AU2005227090B2
(en)
*
|
2004-03-22 |
2010-12-09 |
Abbott Laboratories Gmbh |
Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
|
|
EP1604667A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
|
EP1604666A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
JP5704789B2
(ja)
*
|
2005-01-28 |
2015-04-22 |
ユーロ−セルティーク エス．エイ． |
耐アルコール性剤形
|
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
UA93384C2
(ru)
*
|
2005-07-29 |
2011-02-10 |
Солвей Фармасьютикалс Гмбх |
Способ получения стерилизированного порошкообразного панкреатина
|
|
US11266607B2
(en)
*
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
|
US9198871B2
(en)
*
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
|
US10072256B2
(en)
*
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
US20070286903A1
(en)
*
|
2006-06-13 |
2007-12-13 |
Becicka Brian T |
Composition and method for taste masking
|
|
US20090130063A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Solvay Pharmaceuticals Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
|
EP2317991B1
(en)
*
|
2008-07-07 |
2017-05-03 |
Euro-Celtique S.A. |
Use of opioid antagonists for treating urinary retention
|
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|
|
CN105517551A
(zh)
|
2013-07-23 |
2016-04-20 |
欧洲凯尔特公司 |
用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合
|
